1. Home
  2. AISP vs RCEL Comparison

AISP vs RCEL Comparison

Compare AISP & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$2.79

Market Cap

112.1M

Sector

Finance

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.06

Market Cap

102.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
RCEL
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.1M
102.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AISP
RCEL
Price
$2.79
$4.06
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$7.17
AVG Volume (30 Days)
1.1M
240.3K
Earning Date
03-02-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,033,886.00
$72,401,000.00
Revenue This Year
$34.52
$13.61
Revenue Next Year
$59.54
$19.61
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.59
52 Week Low
$2.69
$3.22
52 Week High
$7.20
$11.25

Technical Indicators

Market Signals
Indicator
AISP
RCEL
Relative Strength Index (RSI) 38.29 53.27
Support Level $2.69 $4.21
Resistance Level $3.30 $4.56
Average True Range (ATR) 0.34 0.28
MACD -0.08 0.01
Stochastic Oscillator 5.86 56.96

Price Performance

Historical Comparison
AISP
RCEL

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: